Robert C. Koski
Known title: DirectorCIK: 0001234880
Robert C. Koski's purchase track record
Robert C. Koski has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/30/2021 | OGEN | $469K | -20.9% | -18.6% | -20.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OGEN | ▼ Sell | Other | 5,000 | — | 12/11/2024 | View on chart |
| OGEN | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 | View on chart |
| OGEN | ▼ Sell | Open Market | 42,357 | $4K | 12/30/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 36,648 | $4K | 12/29/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 140,497 | $25K | 12/15/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 25,000 | $4K | 12/14/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 4,503 | $788 | 12/14/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 48,795 | $10K | 12/9/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 13,036 | $3K | 12/8/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 200,000 | $38K | 11/30/2022 | View on chart |
| OGEN | ▼ Sell | Open Market | 200,000 | $38K | 11/29/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 799,100 | $379K | 12/31/2021 | View on chart |
| OGEN | ▲ Buy | Open Market | 200,900 | $90K | 12/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.